Allelic frequency of the factor V Leiden mutation and of the pro-thrombin gene 20210A mutation in healthy Tunisian population [1]

Thrombosis and Haemostasis

Volumn 91, Issue 4, 2004, Pages 824-825

  Bouaziz, Lobna ^b   Hézard, Nathalie ^b   Touhami, Mahjoub ^b   Potron, Gérard ^b   N'siri, Brahim ^b   Nguyen, Philippe ^a  

^a SERVICE DE DERMATOLOGIE   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; BLOOD CLOTTING FACTOR 5 LEIDEN; DNA; GUANINE; PROTHROMBIN;

3' UNTRANSLATED REGION; ADULT; CONTROLLED STUDY; DNA DETERMINATION; ETHNIC DIFFERENCE; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; LETTER; MALE; NUCLEIC ACID BASE SUBSTITUTION; POLYMERASE CHAIN REACTION; POPULATION GENETICS; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; THROMBOEMBOLISM; TUNISIA;

EID: 1842637226     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1614271     Document Type: Letter

References (12)

1. Dahlbäck B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognised mechanism characterised by poor anti-coagulant response to activated protein C: Prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 1993; 90: 1004-8.
2. Poort SR, Rosendaal FR, Reitsma PH, et al. A common genetic variation in the - untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996; 88: 3698-703.
3. Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet 1995; 346: 1133-4.
4. Pepe G, Rickards O, Vanegas OC, et al. Prevalence of factor V Leiden mutation in non-European populations. Thromb Haemost 1997; 77: 329-31.
5. Hessner MJ, Luhm RA, Pearson SL, et al. Prevalence of prothrombin G20210A, factor V G1691A (Leiden), and methylenetetrahydro-folate reductase (MTHFR) C677T in seven different populations determined by Multiplex allele-specific PCR. Thromb Haemost 1999; 81: 733-8.
6. Chafa O, Reghis A, Aubert A, et al. Prevalence of the FVQ506 (factor V Leiden) mutation in the normal and thrombophilic Algerian population. Br J Haematol 1997; 97: 688-9.
7. Helley D, Chafa O, Yaker NJ, et al. Prevalence of the prothrombin gene 20210A mutation in thrombophilic and healthy Algerian subjects. Thromb Haemost 1999; 82: 1554-5.
8. Mathonnet F, Nadifi S, Serazin-Leroy V, et al. Absence of factor V Leiden mutation and low prothrombin G 20210 A mutation prevalence in a healthy Moroccan population. Thromb Haemost 2002; 88: 1073-4.
9. Hezard N, Cornillet-Lefebvre P, Gillot L, et al. Multiplex ASA PCR for a simultaneous determination of factor V Leiden gene, G→A 20210 prothrombin gene and C→T 677 MTHFR gene mutations.Thromb Haemost 1998; 79: 1054-5.
10. Rosendaal FR, Doggen CJM, Zivelin A, et al. Geographic distribution of the 20210 G to A prothrombin variant. Thromb Haemost 1998; 79: 706-8.
11. Özbek U, Tangün Y. Frequency of factor V Leiden (Arg 506 Gln) in Turkey. Br J Haematol 1997; 97: 504-5.
12. Togrul J, Rustamov R, Grey A, et al. Prevalence of the prothrombin gene G20210A mutation in Azerbaijan. Br J Haematol 2000;108: 887-8.